Reduced Reverse Cholesterol Transport Efficacy in Healthy Men with Undesirable Postprandial Triglyceride Response
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reduced Reverse Cholesterol Transport Efficacy in Healthy Men with Undesirable Postprandial Triglyceride Response
Authors
Keywords
-
Journal
Biomolecules
Volume 10, Issue 5, Pages 810
Publisher
MDPI AG
Online
2020-05-25
DOI
10.3390/biom10050810
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Postprandial Hypertriglyceridaemia Revisited In The Era Of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement
- (2019) Genovefa D. Kolovou et al. Current Vascular Pharmacology
- Levels of prebeta-1 high-density lipoprotein are elevated in 3 phenotypes of dyslipidemia
- (2018) Eveline Oestreicher Stock et al. Journal of Clinical Lipidology
- 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2019
- (2018) DIABETES CARE
- Association of Serum Cholesterol Efflux Capacity With Mortality in Patients With ST-Segment Elevation Myocardial Infarction
- (2018) Maryse Guerin et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease
- (2018) A.David Marais PATHOLOGY
- HDL structure and function is profoundly affected when stored frozen in the absence of cryoprotectants
- (2017) Michael Holzer et al. JOURNAL OF LIPID RESEARCH
- Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease
- (2016) Børge G. Nordestgaard CIRCULATION RESEARCH
- Association of Cholesterol Efflux Capacity With Clinical Features of Metabolic Syndrome: Relevance to Atherosclerosis
- (2016) Julie Gall et al. Journal of the American Heart Association
- Triglycerides and cardiovascular disease
- (2014) Børge G Nordestgaard et al. LANCET
- Enhanced cholesterol efflux to HDL through the ABCA1 transporter in hypertriglyceridemia of type 2 diabetes
- (2014) Hussein N. Yassine et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Endogenous CETP activity as a predictor of cardiovascular risk: Determination of the optimal range
- (2013) Elise F. Villard et al. ATHEROSCLEROSIS
- Functionality of postprandial larger HDL2 particles is enhanced following CETP inhibition therapy
- (2012) Natacha Bellanger et al. ATHEROSCLEROSIS
- Cholesterol Efflux and Metabolic Abnormalities Associated With Low High-Density-Lipoprotein-Cholesterol and High Triglycerides in Statin-Treated Coronary Men With Low-Density Lipoprotein-Cholesterol
- (2011) Rosalinda Posadas-Sánchez et al. AMERICAN JOURNAL OF CARDIOLOGY
- Atheroprotective Reverse Cholesterol Transport Pathway Is Defective in Familial Hypercholesterolemia
- (2011) Natacha Bellanger et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Postprandial lipoprotein metabolism: VLDL vs chylomicrons
- (2011) Katsuyuki Nakajima et al. CLINICA CHIMICA ACTA
- Assessment and Clinical Relevance of Non-Fasting and Postprandial Triglycerides: An Expert Panel Statement
- (2011) Genovefa D. Kolovou et al. Current Vascular Pharmacology
- Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
- (2011) Amit V. Khera et al. NEW ENGLAND JOURNAL OF MEDICINE
- Torcetrapib Differentially Modulates the Biological Activities of HDL2 and HDL3 Particles in the Reverse Cholesterol Transport Pathway
- (2008) Giovanna Catalano et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Enhanced removal of cholesterol from macrophage foam cells to serum from type IV hypertriglyceridemic subjects
- (2007) Nesrine Attia et al. ATHEROSCLEROSIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now